will tirzepatide go back on the shortage list Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots A Major GLP-1 Drug Shortage

It's proven effective in managing weight loss

But for patients trying to understand their options, the picture is no longer as simple as it once was

It also regulates gastric emptying in the stomach

When combined with your metabolic biomarkers (fasting glucose, lipid panel, inflammatory markers), genetic context helps your provider weigh the clinical evidence against your unique biology

It should be used under medical supervision

Other reported or anticipated side effects based on Phase 2 data and the known pharmacology of the drug class include: Injection site reactions redness, bruising, or mild discomfort at the site of subcutaneous injection Fatigue commonly associated with caloric restriction and rapid weight loss Headache reported with GLP-1 receptor agonists as a class Increased heart rate (tachycardia) a known class effect of GLP-1 receptor agonists